Anderson Silva secured his first victory in over 26 months at UFC 183, defeating Nick Diaz via unanimous decision.
According to a recent report from Brazilian newspaper Folha de S. Paulo, however, that win will soon vanish, and his triumph over Diaz will be ruled a no-contest.
Nevada State Athletic Commission executive director Bob Bennett delivered the news to the Brazilian outlet, and Bloody Elbow’s Roy Billington provided the translation: “Yes, it will be ruled a NC (no-contest). I don’t know if he will receive the win bonus after this change. That’s (the) UFC’s call, but a percentage of his purse will be held because of this episode.”
For Silva, this news is not entirely unexpected, as it comes on the heels of a serious offense.
His victory parade was halted just days after UFC 183, when a pre-fight drug test came back showing traces of drostanolone and androstane, two anabolic steroids. Yahoo Sports’ Kevin Iole first reported the news, and it’s been a hot topic in the MMA space since.
Drostanolone and androstane are banned both in and out of competition, so the no-contest will be warranted when it is officially delivered.
This will be the first no-contest on Silva’s 40-fight resume. Diaz, on the other hand, is no stranger to this outcome.
A 2007 win over Takanori Gomi was overturned and changed to a no-contest after Diaz tested positive for marijuana after the fight.
Coincidentally, Diaz has tested positive for marijuana two other times in professional competition: once against Carlos Condit in February 2012 and most recently against Silva at UFC 183. However, he lost the fight in these latter two cases, so a no-contest was not administered on his behalf.
It’s important to keep in mind that, while a no-contest appears imminent for Silva’s UFC 183 victory, nothing has been confirmed yet. Stay tuned to Bleacher Report as the situation develops.
Read more MMA news on BleacherReport.com